Finding may explain chest pain symptoms beyond obstructive epicardial coronary artery dise ...

LOS ANGELES (KABC) -- Doctors know how to spot large artery blockages when someone is experiencing heart attack symptoms, but often not those in the smaller heart ...

BASKING RIDGE, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

A domestic collaborative research study has been published that prospectively analyzed the prevalence and prognosis of ...

Garden-variety exercise stress testing can be used in patients who have angina with nonobstructive coronary arteries (ANOCA) to uncover the presence of coronary microvascular dysfunction (CMD), new ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

Exercise electrocardiographic (ECG) stress tests appeared to reliably indicate that some patients with angina with nonobstructive coronary arteries (ANOCA) actually had coronary microvascular ...

A Maryland woman felt chest pain for days before things took a dramatic turn during a family trip to Williamsburg, Virginia. “I felt this tightness in my chest and pain and discomfort in my left arm.

Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...